Funding for this research was provided by:
Medizinische Universität Wien
Text and Data Mining valid from 2019-10-23
Received: 5 August 2019
Accepted: 4 October 2019
First Online: 23 October 2019
Conflict of interest
: K.M. Gust has received advisory board fees from Cepheid, Roche, MSD, and Ferring; speaker fees from Astellas, AstraZeneca, BMS, Ipsen, Janssen, MSD, and Roche; and meeting/travel expenses from Allergan, Astellas, AstraZeneca, Bayer, BMS, Janssen, MSD, Novartis, Pfizer, Pierre Fabre, and Roche. S.F. Shariat has received advisory board and/or speaker fees from Astellas, AstraZeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Sanochemia, Sanofi, and Wolff. S. Brönimann and D. D’Andrea declare that they have no competing interests.